Shandong Cynda Chemical Co.,Ltd. (SHA:603086)
China · Delayed Price · Currency is CNY 6.74
+0.04 (0.60%)
May 22, 2026, 3:00 PM CST
Shandong Cynda Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,440 | 2,348 | 2,412 | 2,435 | 3,102 | 2,179 |
Other Revenue | 12.4 | 12.4 | 7.04 | 25 | 24.25 | 23.67 |
| 2,452 | 2,360 | 2,419 | 2,460 | 3,126 | 2,203 | |
Revenue Growth (YoY) | -0.80% | -2.43% | -1.68% | -21.29% | 41.92% | 16.19% |
Cost of Revenue | 1,928 | 1,854 | 2,135 | 2,213 | 2,302 | 1,721 |
Gross Profit | 523.94 | 505.99 | 284.41 | 247.15 | 824.04 | 481.62 |
Selling, General & Admin | 243.66 | 236.72 | 222.04 | 263.17 | 252.75 | 189.76 |
Research & Development | 94.67 | 102.55 | 105.61 | 115 | 144.29 | 98.06 |
Other Operating Expenses | 11.97 | 11.47 | 10.75 | 11.18 | 9.24 | 7.29 |
Operating Expenses | 352.27 | 349.52 | 344.39 | 386.74 | 412.78 | 303.28 |
Operating Income | 171.66 | 156.47 | -59.98 | -139.6 | 411.25 | 178.33 |
Interest Expense | -20.72 | -19.77 | -11.03 | -7.09 | -3.52 | -0.46 |
Interest & Investment Income | 8.44 | 9.11 | 7.31 | 7.89 | 6.24 | 21.7 |
Currency Exchange Gain (Loss) | -2.44 | -2.44 | 12.91 | 7.83 | 52.54 | -8.23 |
Other Non Operating Income (Expenses) | -11.87 | -2.24 | -0.43 | -1.78 | -2.14 | -1.86 |
EBT Excluding Unusual Items | 145.07 | 141.13 | -51.22 | -132.74 | 464.38 | 189.48 |
Gain (Loss) on Sale of Investments | 0.01 | 0.2 | -0.38 | -5.79 | -61.31 | 8.59 |
Gain (Loss) on Sale of Assets | -4.28 | -4.05 | -1.7 | -0.71 | -0.59 | -3.44 |
Asset Writedown | -1.55 | - | - | - | - | - |
Other Unusual Items | 14.41 | 14.46 | 10.42 | 7.84 | 10.36 | 7.17 |
Pretax Income | 153.65 | 151.73 | -42.87 | -131.41 | 412.84 | 201.8 |
Income Tax Expense | 15.86 | 14.28 | -17.27 | -29.98 | 31.84 | 24.42 |
Earnings From Continuing Operations | 137.79 | 137.45 | -25.6 | -101.44 | 381.01 | 177.38 |
Minority Interest in Earnings | -0.78 | -0.72 | -0.28 | -2.67 | 0.19 | - |
Net Income | 137.01 | 136.73 | -25.88 | -104.1 | 381.2 | 177.38 |
Net Income to Common | 137.01 | 136.73 | -25.88 | -104.1 | 381.2 | 177.38 |
Net Income Growth | 1330.19% | - | - | - | 114.90% | 0.77% |
Shares Outstanding (Basic) | 442 | 441 | 431 | 434 | 433 | 436 |
Shares Outstanding (Diluted) | 442 | 441 | 431 | 434 | 433 | 436 |
Shares Change (YoY) | 4.09% | 2.27% | -0.58% | 0.13% | -0.58% | 1.04% |
EPS (Basic) | 0.31 | 0.31 | -0.06 | -0.24 | 0.88 | 0.41 |
EPS (Diluted) | 0.31 | 0.31 | -0.06 | -0.24 | 0.88 | 0.41 |
EPS Growth | 1273.94% | - | - | - | 116.16% | -0.27% |
Free Cash Flow | -241.6 | -307.8 | -232.17 | -192.62 | 66.58 | 25.85 |
Free Cash Flow Per Share | -0.55 | -0.70 | -0.54 | -0.44 | 0.15 | 0.06 |
Dividend Per Share | 0.100 | 0.100 | - | - | 0.179 | 0.128 |
Dividend Growth | - | - | - | - | 39.97% | - |
Gross Margin | 21.37% | 21.44% | 11.76% | 10.04% | 26.36% | 21.87% |
Operating Margin | 7.00% | 6.63% | -2.48% | -5.67% | 13.16% | 8.10% |
Profit Margin | 5.59% | 5.79% | -1.07% | -4.23% | 12.20% | 8.05% |
Free Cash Flow Margin | -9.85% | -13.04% | -9.60% | -7.83% | 2.13% | 1.17% |
EBITDA | 429.56 | 403.69 | 144.51 | 28.31 | 524.63 | 257.69 |
EBITDA Margin | 17.52% | 17.10% | 5.97% | 1.15% | 16.78% | 11.70% |
D&A For EBITDA | 257.9 | 247.22 | 204.49 | 167.91 | 113.38 | 79.35 |
EBIT | 171.66 | 156.47 | -59.98 | -139.6 | 411.25 | 178.33 |
EBIT Margin | 7.00% | 6.63% | -2.48% | -5.67% | 13.16% | 8.10% |
Effective Tax Rate | 10.32% | 9.41% | - | - | 7.71% | 12.10% |
Revenue as Reported | 2,452 | 2,360 | 2,419 | 2,460 | 3,126 | 2,203 |
Advertising Expenses | - | 8.45 | 7.03 | 6.92 | 8.2 | 5.31 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.